GSK to acquire Novartis' joint venture stake

27 March 2018 - Deborah Wilkes

Archived

GlaxoSmithKline has agreed to acquire Novartis' 36.5% stake in the consumer healthcare joint venture between the two companies for USD13.0 billion in cash.

Click tags below for more information on topics:

Novartis

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: